Skip to main content
TipRanks
Go Ultimate75% OFF

Lukas biomedical Inc. (6814) Financial Statements

Lukas biomedical Inc. Financial Overview

Lukas biomedical Inc.'s market cap is currently NT$732.80M. The company's EPS TTM is NT$-2.20; its P/E ratio is -8.00; Lukas biomedical Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 179.49MNT$ 189.83MNT$ 231.83MNT$ 184.79MNT$ 157.62M
Gross ProfitNT$ 95.69MNT$ 113.12MNT$ 133.89MNT$ 97.91MNT$ 96.06M
Operating IncomeNT$ -81.16MNT$ -92.14MNT$ -43.56MNT$ -48.47MNT$ -43.06M
EBITDANT$ -56.12MNT$ -62.88MNT$ -12.57MNT$ -10.93MNT$ -361.00K
Net IncomeNT$ -85.63MNT$ -94.38MNT$ -47.35MNT$ -50.07MNT$ -49.49M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 34.75MNT$ 64.71MNT$ 31.80MNT$ 40.26MNT$ 64.81M
Total AssetsNT$ 426.80MNT$ 476.50MNT$ 441.19MNT$ 479.67MNT$ 531.24M
Total DebtNT$ 156.02MNT$ 115.20MNT$ 125.86MNT$ 112.42MNT$ 221.47M
Net DebtNT$ 121.27MNT$ 50.48MNT$ 94.06MNT$ 72.16MNT$ 156.66M
Total LiabilitiesNT$ 186.62MNT$ 150.68MNT$ 161.06MNT$ 152.18MNT$ 244.57M
Stockholders' EquityNT$ 240.19MNT$ 325.82MNT$ 280.13MNT$ 327.49MNT$ 286.68M
Cash Flow
Free Cash FlowNT$ -69.95MNT$ -77.35MNT$ -14.41MNT$ -10.41MNT$ -26.18M
Operating Cash FlowNT$ -61.43MNT$ -70.53MNT$ -11.75MNT$ -7.44MNT$ -16.16M
Investing Cash FlowNT$ -8.64MNT$ -9.79MNT$ -1.66MNT$ 2.87MNT$ -10.33M
Financing Cash FlowNT$ 40.10MNT$ 113.24MNT$ 4.94MNT$ -19.98MNT$ 52.25M

Currency in TWD

Lukas biomedical Inc. Earnings and Revenue History

-150M0150M300M-60 %-40 %-20 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Lukas biomedical Inc. Liabilities to Assets

0200M400M600M30 %36 %42 %48 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Lukas biomedical Inc. Cash Flow

-100M-50M050M100M150M201720182019202020212022202320242025OperatingInvestingFinancing

Lukas biomedical Inc. Forecast EPS vs Actual EPS